Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "domestic"

471 News Found

Wellness travel is moving closer to home: What’s driving the shift?
Opinion | April 27, 2026

Wellness travel is moving closer to home: What’s driving the shift?

India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle


Cipla wins USFDA nod for first generic of Ventolin HFA strengthening respiratory push
Drug Approval | April 27, 2026

Cipla wins USFDA nod for first generic of Ventolin HFA strengthening respiratory push

The approval makes Cipla’s product the first AB-rated generic therapeutic equivalent of Ventolin HFA


DSS Imagetech to host webinar series on advanced imaging technologies
News | April 25, 2026

DSS Imagetech to host webinar series on advanced imaging technologies

The webinar series will showcase next-gen imaging technologies, global expert insights, and hands-on sessions on microscopy innovations


Shilpa Medicare appoints Dr Vellaian Karuppiah as COO – Formulations
People | April 24, 2026

Shilpa Medicare appoints Dr Vellaian Karuppiah as COO – Formulations

Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business


PAGE, 8chili Inc. collaborate to scale AI-powered pharma training ecosystem
Digitisation | April 23, 2026

PAGE, 8chili Inc. collaborate to scale AI-powered pharma training ecosystem

Platform integrates VR simulations and AI-driven coaching to build job-ready skills in pharma manufacturing


Cipla’s generic Ventolin HFA secures USFDA approval
Drug Approval | April 23, 2026

Cipla’s generic Ventolin HFA secures USFDA approval

Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market


Strengthening India’s pharma brand through compliance-first manufacturing: Vijay Kumar Aggarwal, MD, Medicef Pharma
Opinion | April 21, 2026

Strengthening India’s pharma brand through compliance-first manufacturing: Vijay Kumar Aggarwal, MD, Medicef Pharma

By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership


Pharma stocks face Q4 reality check amid global headwinds
News | April 20, 2026

Pharma stocks face Q4 reality check amid global headwinds

Analysts expect modest revenue growth but pressure on profitability in the March quarter


Rubicon forays into India's CNS segment with Rs 175.92 crore Arinna buy
News | April 16, 2026

Rubicon forays into India's CNS segment with Rs 175.92 crore Arinna buy

Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%


Former health minister Dr Harsh Vardhan visits Wadi Surgicals’ nitrile glove facility at AMTZ
Medical Device | April 16, 2026

Former health minister Dr Harsh Vardhan visits Wadi Surgicals’ nitrile glove facility at AMTZ

Visit underscores push for self-reliance in essential medical consumables and India’s ambition to become a global medtech manufacturing hub